资讯
High-speed optical modulator adoption is expected to increase from USD 43.2 billion in 2025. By 2035, it is projected to have ...
Home > Press release: Successful Development of Innovative and ...
The full invitation to the AGM 2025 may be found in the General Meetings section of the Company's website here.
Sionna Therapeutics is a clinical-stage biopharmaceutical company on a mission to revolutionize the current treatment ...
Endogenous intracellular allosteric modulators of GPCRs remain largely unexplored, with limited binding and phenotype data available. This gap arises from the lack of robust computational methods for ...
Genmab A/S (NASDAQ:GMAB) has announced promising new data for its investigational antibody-drug conjugate, rinatabart ...
Inmed Pharmaceuticals Inc. has divulged cannabinoid CB1 and/or CB2 receptor modulators reported to be useful for the treatment of neurodegeneration and age-related macular degeneration.
Cuts in NIH grants and the threat of more are discouraging investment and may drive trials out of the United States.
A doctor has revealed that there are 5 daily diet changes that people should try to help ease their pain. Dr Safia Debar, ...
Abstract: This tutorial describes the basic principles and performance analysis of optical intensity modulators using electrooptic and electroabsorption effects, for use in analog and digital ...
The demand for optical components is projected to be at $100 billion by 2030, and the company expects to enter this market with its modulators integrated into communication chips and photonic systems.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果